Generation Bio (GBIO) Stock Forecast & Price Target

$1.38 +0.03 (+2.01%)

(As of 09:33 AM ET)

Generation Bio - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 2 Analyst Ratings

Sell
0

Hold
0

Buy
2

Based on 2 Wall Street analysts who have issued ratings for Generation Bio in the last 12 months, the stock has a consensus rating of "Buy." Out of the 2 analysts, 2 have given a buy rating for GBIO.

Consensus Price Target

$7.50
444.62% Upside

According to the 2 analysts' twelve-month price targets for Generation Bio, the average price target is $7.50. The highest price target for GBIO is $10.00, while the lowest price target for GBIO is $5.00. The average price target represents a forecasted upside of 444.62% from the current price of $1.38.

Get the Latest News and Ratings for GBIO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Generation Bio and its competitors.

GBIO Analyst Ratings Over Time

Type	Current Forecast 11/22/23 to 11/21/24	1 Month Ago 10/23/23 to 10/22/24	3 Months Ago 8/24/23 to 8/23/24	1 Year Ago 11/22/22 to 11/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)
Hold	0 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$7.50	$7.50	$7.50	$8.56
Forecasted Upside	444.62% Upside	221.89% Upside	183.02% Upside	644.13% Upside
Consensus Rating	Buy	Moderate Buy	Hold	Hold

Trump said you could learn something from this man (Ad)

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.

GBIO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GBIO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Generation Bio Stock vs. The Competition

Type	Generation Bio	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.80	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	455.56% Upside	26,931.55% Upside	9.81% Upside
News Sentiment Rating	Positive News See Recent GBIO News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
11/7/2024	Wedbush 4 of 5 stars	Reiterated Rating	Outperform	$5.00	+110.08%
10/23/2024	Needham & Company LLC 2 of 5 stars	Reiterated Rating	Buy ➝ Buy	$10.00 ➝ $10.00	+329.18%
11/10/2023	William Blair 2 of 5 stars	Reiterated Rating	Market Perform
10/23/2023	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Perform
10/19/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
8/16/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$8.00 ➝ $9.00	+97.80%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:53 AM ET.

GBIO Forecast - Frequently Asked Questions

: According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Generation Bio is $7.50, with a high forecast of $10.00 and a low forecast of $5.00.
: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Generation Bio in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GBIO shares.
: According to analysts, Generation Bio's stock has a predicted upside of 444.62% based on their 12-month stock forecasts.
: Generation Bio has been rated by research analysts at Needham & Company LLC, and Wedbush in the past 90 days.
: Analysts like Generation Bio more than other "medical" companies. The consensus rating for Generation Bio is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how GBIO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Trump said you could learn something from this man (Ad)

Here’s everything you need to know.

This page (NASDAQ:GBIO) was last updated on 11/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Generation Bio (GBIO) Stock Forecast & Price Target